Skip to content
Search

Latest Stories

As medicine shortages are found to be a Europe-wide problem, NPA calls for urgent action

Medicines shortages are a growing problem in the UK as well as across Europe, a recent survey has revealed.

According to a Pharmaceutical Group of European Union (PGEU) survey, pharmacy associations in most European countries admitted to having experienced medicine shortages in 2019, while 92 per cent of the countries reported shortages affecting patient's trust in community pharmacies.


In the majority of responding countries, over 200 medicines were listed as being in short supply and pharmacy staff were said to be spending an average of six hours per week on dealing with shortages.

The survey also identified a gap in information, tools and legal solution to community pharmacists in many European countries for providing the solution to patients in case of a shortage.

“All responding countries indicated that they believe medicine shortages caused distress and inconvenience to patients,” it further revealed.

NPA CALLS FOR URGENT ACTION

Commenting on the survey, the National Pharmacy Association (NPA) called for urgent action and said the data was further evidence of a widespread problem in the UK and across Europe.

“Because of heroic efforts by pharmacists, patients usually get their medicines when and where they need them, but longstanding faults in the medicines supply chain too often leave patients waiting. It’s time for urgent action, to reduce the risk of harm and to allow pharmacists to spend more time with patients instead of hunting for stock,” said NPA Policy Manager Helga Mangion.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less